|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1995-12-22
|
|
pubmed:abstractText |
Serum levels of soluble interleukin-2 receptor (sIL-2R) seem to serve as a marker for the activation of T lymphocytes. The aim of this study was to evaluate the clinical significance of such levels in patients with chronic hepatitis C (CHC) treated with interferon.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0036-5521
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
807-11
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:7481551-Adult,
pubmed-meshheading:7481551-Alanine Transaminase,
pubmed-meshheading:7481551-Female,
pubmed-meshheading:7481551-Hepacivirus,
pubmed-meshheading:7481551-Hepatitis, Chronic,
pubmed-meshheading:7481551-Hepatitis C,
pubmed-meshheading:7481551-Humans,
pubmed-meshheading:7481551-Interferon-alpha,
pubmed-meshheading:7481551-Lymphocyte Activation,
pubmed-meshheading:7481551-Male,
pubmed-meshheading:7481551-Middle Aged,
pubmed-meshheading:7481551-RNA, Viral,
pubmed-meshheading:7481551-Receptors, Interleukin-2,
pubmed-meshheading:7481551-Recombinant Proteins,
pubmed-meshheading:7481551-T-Lymphocytes,
pubmed-meshheading:7481551-Treatment Outcome
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Serum levels of soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alpha.
|
|
pubmed:affiliation |
Dept. of Gastroenterology, Ogaki Municipal Hospital, Gifu, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
